C12N 2501/48
Regulators of apoptosis
C12N2501/48 (Regulators of apoptosis) appears on 152 US grants and 298 published applications in this corpus.
Search patents in C12N- Granted patents
- 152
- Published applications
- 298
- Assignees
- 173
- Inventors
- 527
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 2 | 3 |
| 2002 | 0 | 4 |
| 2003 | 6 | 3 |
| 2004 | 0 | 5 |
| 2005 | 0 | 2 |
| 2006 | 1 | 6 |
| 2007 | 2 | 12 |
| 2008 | 1 | 9 |
| 2009 | 4 | 19 |
| 2010 | 8 | 15 |
| 2011 | 7 | 10 |
| 2012 | 4 | 10 |
| 2013 | 8 | 10 |
| 2014 | 9 | 13 |
| 2015 | 11 | 11 |
| 2016 | 7 | 18 |
| 2017 | 16 | 12 |
| 2018 | 12 | 18 |
| 2019 | 5 | 13 |
| 2020 | 10 | 13 |
| 2021 | 13 | 20 |
| 2022 | 4 | 23 |
| 2023 | 4 | 14 |
| 2024 | 5 | 13 |
| 2025 | 7 | 16 |
| 2026 | 6 | 6 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fixed ratio ex vivo activated mixed lymphocyte products for use in the treatment of cancer22 Sep 2026US 12,742,153 B2Children's National Medical Center
- Methods and compositions for generating oligodendrocyte progenitor cells8 Sep 2026US 12,729,368 B2Trailhead Biosystems Inc.
- Immunomodulatory cells and uses thereof12 May 2026US 12,622,932 B2Sinai Health System
- Altering gene expression in modified T cells and uses thereof17 Mar 2026US 12,577,567 B2The Trustees of the University of Pennsylvania
- Methods and compositions for promoting non-natural amino acid-containing protein production17 Mar 2026US 12,577,575 B2Ambrx, Inc.
- Immunomodulatory cells and uses thereof30 Jul 2026US 2026/0216252 A1Sinai Health System
- Method for producing gamma delta t cells4 Jun 2026US 2026/0152541 A1Kyoto University
- Method for producing gamma delta t cells4 Jun 2026US 2026/0152542 A1Kyoto University
- Natural killer cell products and methods12 Feb 2026US 2026/0042813 A1Board of Regents, The University of Texas System
- Altering gene expression in cart cells and uses thereof12 Feb 2026US 2026/0043032 A1The Trustees of the University of Pennsylvania
Most cited
By later US patents
- Vectors and methods for the efficient generation of integration/transgene-free induced pluripotent stem cells from peripheral blood cells126US 9,850,499 B2Loma Linda University · 2017
- Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulation46US 8,617,884 B2Life Technologies Corporation · 2013
- Methods for eliminating at least a substantial portion of a clonal antigen-specific memory T cell subpopulation44US 9,528,088 B2Life Technologies Corporation · 2016
- Methods for inducing selective apoptosis34US 9,089,520 B2Baylor College of Medicine · 2015
- Compositions and methods for modulating apoptosis in cells over-expressing Bcl-2 family member proteins26US 7,241,804 B1Fred Hutchinson Cancer Research Center · 2007